Bristol-Myers Squibb Business Finance Contracts & Agreements
80 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Credit Agreements (24)
- Debenture Agreements (1)
- Exchange Agreements (5)
- Funding Agreements (1)
- Indenture Agreements (10)
- Loan Agreements (2)
- Note Agreements (13)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Security Agreements (1)
- Stock Agreements (8)
- Trust Agreements (1)
- Underwriting Agreements (9)
- Waiver Agreements (1)
- Fifteenth Supplemental Indenture, dated as of February 22, 2024, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as... (Filed With SEC on February 22, 2024)
- Underwriting Agreement, dated February 14, 2024, among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on February 22, 2024)
- Fourteenth Supplemental Indenture, dated as of November 13, 2023, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated... (Filed With SEC on November 13, 2023)
- Underwriting Agreement, dated October 30, 2023, by and among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on November 13, 2023)
- Thirteenth Supplemental Indenture, dated as of March 2, 2022, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as of... (Filed With SEC on March 2, 2022)
- Underwriting Agreement, dated February 15, 2022, among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on February 22, 2022)
- Amendment, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,... (Filed With SEC on July 28, 2021)
- Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 (Filed With SEC on July 28, 2021)
- Amendment and Waiver, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers... (Filed With SEC on July 28, 2021)
- Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 (Filed With SEC on July 28, 2021)
- Amendment, dated as of January 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,... (Filed With SEC on February 10, 2021)
- Amendment, dated as of January 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers Squibb... (Filed With SEC on February 10, 2021)
- Extension Notice, dated January 4, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 (Filed With SEC on February 10, 2021)
- Extension Notice, dated January 4, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 (Filed With SEC on February 10, 2021)
- Twelfth Supplemental Indenture, dated as of November 13, 2020, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as... (Filed With SEC on November 13, 2020)
- Underwriting Agreement, dated November 9, 2020, among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on November 13, 2020)
- Term Loan Agreement, dated as of November 4, 2020, by and among Bristol-Myers Squibb Company, the lenders party thereto and Citibank, N.A., administrative agent (Filed With SEC on November 6, 2020)
- Amendment and Waiver, dated as of June 17, 2020, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb... (Filed With SEC on August 6, 2020)
- Amendment and Waiver, dated as of June 17, 2020, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers... (Filed With SEC on August 6, 2020)
- Contingent Value Rights Agreement, dated as of November 20, 2019, by and between Bristol-Myers Squibb Company and Equiniti Trust Company, as trustee, including the Form of CVR... (Filed With SEC on February 24, 2020)
- Assignment, Assumption and Amendment Agreement, dated as of November 20, 2019, among Bristol-Myers Squibb Company, Celgene Corporation, American Stock Transfer & Trust Company,... (Filed With SEC on November 20, 2019)
- Amendment, dated as of June 20, 2019, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,... (Filed With SEC on July 25, 2019)
- Extension Notice, dated May 31, 2019, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 (Filed With SEC on July 25, 2019)
- Amendment and Waiver, dated as of June 20, 2019, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers... (Filed With SEC on July 25, 2019)
- Extension Notice, dated May 31, 2019, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 (Filed With SEC on July 25, 2019)
- Purchase Agreement, dated May 7, 2019, by and between Bristol-Myers Squibb Company and the initial purchasers named therein (Filed With SEC on May 8, 2019)
- Three-Year Revolving Credit Facility Agreement, dated as of January 25, 2019, by and among Bristol-Myers Squibb Company, the lenders party thereto and Morgan Stanley Senior... (Filed With SEC on January 30, 2019)
- 364-Day Revolving Credit Facility Agreement, dated as of January 25, 2019, by and among Bristol-Myers Squibb Company, the lenders party thereto and, Citibank, N.A. and JPMorgan... (Filed With SEC on January 30, 2019)
- Term Loan Agreement, dated as of January 18, 2019, by and among Bristol-Myers Squibb Corporation, the lenders party thereto and Morgan Stanley Senior Funding, Inc., as... (Filed With SEC on January 22, 2019)
- Bridge Facility Commitment Letter, dated as of January 2, 2019, among Morgan Stanley Senior Funding, Inc., MUFG Bank, Ltd. and Bristol-Myers Squibb Company (Filed With SEC on January 4, 2019)
- Extension to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 (Filed With SEC on July 26, 2018)
- Extension to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 (Filed With SEC on July 26, 2018)
- Amendment dated as of June 26, 2017, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company, the... (Filed With SEC on July 27, 2017)
- Amendment and Waiver dated as of June 26, 2017, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers... (Filed With SEC on July 27, 2017)
- BRISTOL-MYERS SQUIBB COMPANY and THE BANK OF NEW YORK MELLON, Trustee NINTH SUPPLEMENTAL INDENTURE Dated as of February 27, 2017 to INDENTURE Dated as of June1, 1993 1.600% Notes... (Filed With SEC on February 27, 2017)
- UNDERWRITING AGREEMENT, dated as of February 22, 2017 Bristol-Myers Squibb Company 1.600% Notes due 2019 3.250% Notes due 2027 (Filed With SEC on February 27, 2017)
- AMENDMENT AND WAIVER (Filed With SEC on July 28, 2016)
- (FACE OF NOTE) (Filed With SEC on May 5, 2015)
- (FACE OF NOTE) (Filed With SEC on May 5, 2015)
- BRISTOL-MYERS SQUIBB COMPANY and THE BANK OF NEW YORK MELLON, Trustee EIGHTHSUPPLEMENTAL INDENTURE Dated as of May 5, 2015 to INDENTURE Dated as of June 1, 1993 1.000% Notes... (Filed With SEC on May 5, 2015)